Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06065436 · ClinicalTrials.gov registry record · NA

Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease

A NA study of Erectile Dysfunction and Peyronie Disease, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06065436 is a NA study of Erectile Dysfunction and Peyronie Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06065436, a NA study of Erectile Dysfunction and Peyronie Disease, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to determine whether or not low-intensity shockwave therapy (LiSWT) with Xiaflex treatment will result in greater improvements to the curvature of the penis.

Interventions

  • DRUG Collagenase Clostridium Histolyticum
  • DEVICE Storz Duolith LiSWT

Study Locations (1)

Minnesota

  • Mayo Clinic Minnesota - Rochester

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-01-19
Est. Completion 2027-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06065436

The ClinicalTrials.gov registry entry for NCT06065436 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (74% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Collagenase Clostridium Histolyticum is the first listed.

NCT06065436 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06065436 about?

NCT06065436 is a clinical study titled "Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease". The purpose of this research is to determine whether or not low-intensity shockwave therapy (LiSWT) with Xiaflex treatment will result in greater improvements to the curvature of the penis.

What is the current status of trial NCT06065436?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-01-19. Estimated completion is 2027-01.

What conditions does trial NCT06065436 study?

This clinical trial studies the following conditions: Erectile Dysfunction, Peyronie Disease.

What interventions are being tested in trial NCT06065436?

The interventions under investigation include: Collagenase Clostridium Histolyticum (DRUG), Storz Duolith LiSWT (DEVICE).

Who is sponsoring clinical trial NCT06065436?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06065436 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Erectile Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.